Trials / Completed
CompletedNCT04317053
Multi-Center Randomized Controlled Trial of Relay- NYC's Nonfatal Overdose Response Program
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 253 (actual)
- Sponsor
- NYU Langone Health · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The New York City (NYC) Department of Health and Mental Hygiene (DOHMH) has implemented Relay, a novel program that engages and intervenes with individuals in the ED following an opioid OD and for the next 90 days, with the goal of preventing subsequent OD events. The proposed randomized controlled trial will evaluate the impact of Relay on preventing subsequent opioid-related adverse events. A total of 350 eligible individuals with nonfatal opioid OD presenting to one of four participating EDs will be enrolled and randomized to one of two arms: 1) site-directed care (SDC) or 2) Relay-peer-delivered OD education and treatment linkage, including 90 days of peer navigation. Outcomes will be measured for 12 months through interviews and administrative health data.
Detailed description
Relay is a novel program that engages and intervenes with individuals in the ED following an opioid OD and for the next 90 days, with the goal of preventing subsequent OD events. Relay is delivered by trained peer navigators, who are DOHMH staff with lived substance use experience. Relay navigators provide counseling, linkage to services, and OD prevention education.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | RELAY | Relay is a novel program that engages and intervenes with individuals in the ED following an opioid OD and for the next 90 days, with the goal of preventing subsequent OD events. Relay is delivered by trained peer navigators, who are DOHMH staff with lived substance use experience. Relay navigators provide counseling, linkage to services, and OD prevention education. |
Timeline
- Start date
- 2020-10-08
- Primary completion
- 2023-07-01
- Completion
- 2023-07-01
- First posted
- 2020-03-20
- Last updated
- 2024-11-25
- Results posted
- 2024-11-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04317053. Inclusion in this directory is not an endorsement.